NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID is one of the 27 Institutes and Centers of the National Institutes of Health (NIH).
Why Is Global Research a Priority for NIAID?
The impact of debilitating diseases, such as HIV/AIDS, malaria, and tuberculosis, extends from individuals to families and into the broader society.
With infectious diseases among the primary causes of mortality and suffering worldwide, the morbidity and mortality associated with these diseases in developing countries can slow or reverse social and economic development.
How Is NIAID Addressing This Critical Topic?
Global research is an integral part of many research projects, programs, initiatives, and other activities implemented by the NIAID extramural and intramural divisions. Conducting research in international settings allows NIAID-supported scientists to study infectious diseases and immunology under a variety of environmental and social conditions. It also provides opportunities to study the effectiveness of investigational drugs and vaccines in populations that vary genetically and immunologically, in the hope of finding treatments and preventions for wide ranges of disease strains and mutations.
With NIAID support, the discoveries of scientists in the United States and around the world are helping to improve the health of millions of individuals, advance public health policy and clinical practice, protect the United States against infectious disease threats, and promote international wellbeing. In executing its mandate, NIAID helps lead global health research and health diplomacy.
NIAID has embraced its leadership role in the global effort to defeat these diseases. By working with partners in academia, private industry, philanthropic foundations, and other research-supporting agencies, NIAID contributes to global development and stability, and enhances research that improves the quality of human life around the world.
Learn more in Global Research Questions and Answers
Latest News Releases
Experimental Nasal Influenza Vaccine Tested in Kids, Teens
September 17, 2018
Early-Stage Clinical Trial of Antimalarial Drug Begins
September 10, 2018
NIAID Now Blog
NIAID Research: The Director's Cut
August 27, 2018